Bio-Techne Corporation
TECH · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,220 | $1,159 | $1,137 | $1,106 |
| % Growth | 5.2% | 2% | 2.8% | – |
| Cost of Goods Sold | $429 | $389 | $367 | $349 |
| Gross Profit | $790 | $770 | $770 | $756 |
| % Margin | 64.8% | 66.4% | 67.7% | 68.4% |
| R&D Expenses | $99 | $97 | $92 | $87 |
| G&A Expenses | $415 | $393 | $352 | $339 |
| SG&A Expenses | $415 | $393 | $352 | $339 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $173 | $73 | $26 | $34 |
| Operating Expenses | $688 | $563 | $471 | $460 |
| Operating Income | $102 | $207 | $299 | $297 |
| % Margin | 8.4% | 17.8% | 26.3% | 26.8% |
| Other Income/Exp. Net | -$4 | -$21 | $40 | $5 |
| Pre-Tax Income | $98 | $186 | $339 | $301 |
| Tax Expense | $25 | $18 | $53 | $38 |
| Net Income | $73 | $168 | $285 | $272 |
| % Margin | 6% | 14.5% | 25.1% | 24.6% |
| EPS | 0.47 | 1.07 | 1.81 | 1.73 |
| % Growth | -56.1% | -40.9% | 4.6% | – |
| EPS Diluted | 0.46 | 1.05 | 1.76 | 1.66 |
| Weighted Avg Shares Out | 158 | 158 | 157 | 157 |
| Weighted Avg Shares Out Dil | 160 | 161 | 162 | 164 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $3 | $1 |
| Interest Expense | $9 | $16 | $11 | $11 |
| Depreciation & Amortization | $110 | $112 | $107 | $101 |
| EBITDA | $217 | $313 | $457 | $414 |
| % Margin | 17.8% | 27% | 40.2% | 37.4% |